Jérôme Berger
- Molecular Medicine top 0.5%
- Hydrogels: synthesis, properties, applications 4
- Pharmaceutical Science top 0.5%
- Biomaterials top 0.5%
- Surfaces, Coatings and Films top 1%
- Rehabilitation top 5%
-
- Pharmaceutical Practices and Patient Outcomes 17
-
- Medication Adherence and Compliance 8
-
- Pharmaceutical studies and practices 7
-
- Immunodeficiency and Autoimmune Disorders 4
-
- SARS-CoV-2 and COVID-19 Research 3
-
- Health, Medicine and Society 3
-
- Autoimmune Bullous Skin Diseases 3
- Co-authors
- Robert GurnyMarianne ReistJoachim M. MayerOlivia FeltNicholas A. PeppasOlivier BugnonO. Felt-BaeyensA. Chenite
- Partner nations
- SwitzerlandUnited StatesGermany
In The Last Decade
Jérôme Berger
53 papers receiving 2.9k citations
Hit Papers
Peers
Comparison fields: 5 of 153
- Molecular Medicine 842
- Pharmaceutical Science 699
- Biomaterials 1.3k
- Surfaces, Coatings and Films 396
- Rehabilitation 139
Countries citing papers authored by Jérôme Berger
This map shows the geographic impact of Jérôme Berger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jérôme Berger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jérôme Berger more than expected).
Fields of papers citing papers by Jérôme Berger
This network shows the impact of papers produced by Jérôme Berger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jérôme Berger. The network helps show where Jérôme Berger may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jérôme Berger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 1 | |
| 5 | 2022 | 1 | |
| 6 | 2021 | 19 | |
| 7 | 2021 | 8 | |
| 8 | 2021 | 4 | |
| 9 | 2018 | 4 | |
| 10 | 2018 | 1 | |
| 11 | 2018 | 23 | |
| 12 | 2015 | 1 | |
| 13 | [Subcutaneous immunoglobulin and support program: what level of interest of patients?]. | 2015 | 4 |
| 14 | 2012 | 8 | |
| 15 | 2011 | 3 | |
| 16 | 2004 | 75 | |
| 17 | Structure and interactions in chitosan hydrogels formed by complexation or aggregation for biomedical applicationsbreakdown → | 2003 | 776 |
| 18 | Structure and interactions in covalently and ionically crosslinked chitosan hydrogels for biomedical applicationsbreakdown → | 2003 | 1691 |
| 19 | 2000 | 29 | |
| 20 | 1957 | 2 |
About Jérôme Berger
Jérôme Berger is a scholar working on Geriatrics and Gerontology, Family Practice, Applied Microbiology and Biotechnology, Molecular Medicine and Health, having authored 63 papers that have together received 3.0k indexed citations. Recurring topics across this work include Pharmaceutical Practices and Patient Outcomes (17 papers), Medication Adherence and Compliance (8 papers), Pharmaceutical studies and practices (7 papers), Hydrogels: synthesis, properties, applications (4 papers), Immunodeficiency and Autoimmune Disorders (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Health, Medicine and Society (3 papers) and Autoimmune Bullous Skin Diseases (3 papers). The work is most often cited by research in Molecular Medicine (842 citations), Pharmaceutical Science (699 citations), Biomaterials (1.3k citations), Surfaces, Coatings and Films (396 citations) and Rehabilitation (139 citations). Jérôme Berger has collaborated with scholars based in Switzerland, United States and Germany. Frequent co-authors include Robert Gurny, Marianne Reist, Joachim M. Mayer, Olivia Felt, Nicholas A. Peppas, Olivier Bugnon, O. Felt-Baeyens, A. Chenite, Donald J. D’Amico and Marie Paule Schneider. Their work appears in journals such as Vaccines, PLoS ONE, Gynecologic and Obstetric Investigation, Journal of Evaluation in Clinical Practice and Research in Social and Administrative Pharmacy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.